L- and T-type calcium channels control aldosterone production from human adrenals
Reads0
Chats0
TLDR
It is concluded that T- and L-type calcium channels play equally important roles in controlling aldosterone production from human adrenals.Abstract:
Aldosterone, which plays a key role in the regulation of blood pressure, is produced by zona glomerulosa (ZG) cells of the adrenal cortex. Exaggerated overproduction of aldosterone from ZG cells causes primary hyperaldosteronism. In ZG cells, calcium entry through voltage-gated calcium channels plays a central role in the regulation of aldosterone secretion. Previous studies in animal adrenals and human adrenal adrenocortical cell lines suggest that the T-type but not the L-type calcium channel activity drives aldosterone production. However, recent clinical studies show that somatic mutations in L-type calcium channels are the second most prevalent cause of aldosterone-producing adenoma. Our objective was to define the roles of T and L-type calcium channels in regulating aldosterone secretion from human adrenals. We find that human adrenal ZG cells mainly express T-type CaV3.2/3.3 and L-type CaV1.2/1.3 calcium channels. TTA-P2, a specific inhibitor of T-type calcium channel subtypes, reduced basal aldosterone secretion from acutely prepared slices of human adrenals. Surprisingly, nifedipine, the prototypic inhibitor of L-type calcium channels, also decreased basal aldosterone secretion, suggesting that L-type calcium channels are active under basal conditions. In addition, TTA-P2 or nifedipine also inhibited aldosterone secretion stimulated by angiotensin II- or elevations in extracellular K+. Remarkably, blockade of either L- or T-type calcium channels inhibits basal and stimulated aldosterone production to a similar extent. Low concentrations of TTA-P2 and nifedipine showed additive inhibitory effect on aldosterone secretion. We conclude that T- and L-type calcium channels play equally important roles in controlling aldosterone production from human adrenals.read more
Citations
More filters
Journal ArticleDOI
Targeting microglia L-type voltage-dependent calcium channels for the treatment of central nervous system disorders
TL;DR: The literature on L‐VDCC expression and function in the CNS and on microglia in vitro and in vivo is reviewed and the therapeutic landscape of L-VDCC‐targeting agents at present and future challenges in the context of Alzheimer's disease, Parkinson’s disease, Huntington's Disease, neuropsychiatric diseases, and other CNS disorders are explored.
Journal ArticleDOI
Cellular Pathophysiology of Mutant Voltage-Dependent Ca2+ Channel CACNA1H in Primary Aldosteronism.
Florian Gürtler,Katrin Jordan,Ines Tegtmeier,Janina Herold,Julia Stindl,Richard Warth,Sascha Bandulik +6 more
TL;DR: The pathogenesis of stimulus-independent aldosterone production in patients with CACNA1H mutations involves several factors: a loss of normal control of the membrane potential, an increased Ca2+ influx at basal conditions, and alterations in sensitivity to extracellular K+ and Na+.
Journal ArticleDOI
The role of lipid second messengers in aldosterone synthesis and secretion
TL;DR: In this article , the authors examine the mechanisms by which these lipid second messengers modulate aldosterone production at multiple levels. But, they also highlight the gaps in their knowledge, such as the preference for phospholipase D-generated PA or DAG, as well as the need for further investigation to elucidate the precise mechanism by which those lipid secondmessengers regulate optimal aldosteronism.
Journal ArticleDOI
Cav1.3‐selective inhibitors of voltage‐gated L‐type Ca2+ channels: Fact or (still) fiction?
TL;DR: In this article , the authors conclude that at present no pharmacological tools exist that are suitable to confirm or refute a role of Cav1.3 channels in cellular responses in preclinical models.
Journal ArticleDOI
Visualization of calcium channel blockers in human adrenal tissues and their possible effects on steroidogenesis in the patients with primary aldosteronism (PA)
Naoki Motomura,Yu Yamazaki,Xin-cheng Gao,Yuta Tezuka,Kei Omata,Yoshikiyo Ono,Ryo Morimoto,Fumitoshi Satoh,Yasuhiro Nakamura,Jaeyoon Shim,Man Ho Choi,Akihiro Ito,Hironobu Sasano +12 more
TL;DR: In this article , a matrix-assisted laser desorption/ionization mass spectrometry imaging (MALDI-MSI) was performed to quantify amlodipine and 17 adrenal steroids.
References
More filters
Journal ArticleDOI
Molecular Physiology of Low-Voltage-Activated T-type Calcium Channels
TL;DR: The goal of this review is to provide a comprehensive description of T-type currents, their distribution, regulation, pharmacology, and cloning.
Journal ArticleDOI
Case Detection, Diagnosis, and Treatment of Patients with Primary Aldosteronism : An Endocrine Society Clinical Practice Guideline
John W. Funder,Robert M. Carey,Carlos E. Fardella,Celso E. Gomez-Sanchez,Franco Mantero,Michael Stowasser,William F. Young,Victor M. Montori +7 more
TL;DR: The Task Force developed clinical practice guidelines for the diagnosis and treatment of patients with primary aldosteronism and recommended that patients with bilateral adrenal hyperplasia, or those unsuitable for surgery, optimally be treated medically by mineralocorticoid receptor antagonists.
Journal ArticleDOI
A Prospective Study of the Prevalence of Primary Aldosteronism in 1,125 Hypertensive Patients
Gian Paolo Rossi,Giampaolo Bernini,C. Caliumi,Giovambattista Desideri,Bruno Fabris,Claudio Ferri,Chiara Ganzaroli,Gilberta Giacchetti,Claudio Letizia,Mauro Maccario,Francesca Mallamaci,Massimo Mannelli,Mee-Jung Mattarello,A. Moretti,Gaetana Palumbo,Gabriele Parenti,Enzo Porteri,Andrea Semplicini,Damiano Rizzoni,Ermanno Rossi,Marco Boscaro,Achille C. Pessina,Franco Mantero,Papy Study Investigators +23 more
TL;DR: In newly diagnosed hypertensive patients referred to hypertension centers, the prevalence of APA is high (4.8%) and the availability of AVS is essential for an accurate identification of the adrenocortical pathologies underlying PA.
Journal ArticleDOI
A chimaeric 11 beta-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension.
Richard P. Lifton,Robert G. Dluhy,Michael Powers,Glenn M. Rich,Sandra Cook,Stanley Ulick,Jean-Marc Lalouel +6 more
TL;DR: This work demonstrates complete linkage of GRA in a large kindred to a gene duplication arising from unequal crossing over, fusing the 5' regulatory region of 11β-hydroxylase to the coding sequences of aldosterone synthase.
Journal ArticleDOI
Hyperaldosteronism Among Black and White Subjects With Resistant Hypertension
TL;DR: The data provide strong evidence that hyperaldosteronism is a common cause of resistant hypertension in black and white subjects and the accuracy of these results is strengthened by having done suppression testing of all evaluated subjects.